“…Although the pathogenesis of NAFLD remains poorly understood, NAFLD is strongly associated with metabolic syndrome, a wellestablished clinical constellation of central obesity, type-2 diabetes mellitus, arterial hypertension, and dyslipidemia [2,[19][20][21]. The strong association of obesity with NAFLD suggests that obesity contributes to the pathogenesis of liver injury by steatosis and progression to steatohepatitis [2,20,22,23]. The prevalence of NAFLD and non-alcoholic steatohepatitis (NASH) in obese patients ranges from 69-100% to 25-30% of cases, respectively [24][25][26].…”